Skip to content

Massive Bio

500 Global 2016 · Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials.

Competitors

Adjacent

Also from 500 Global in AI

All of 500 Global

Programs

Programs Massive Bio went through
ProgramCohortSource
500 Global2016500 Global Page

About Massive Bio

Developer of an artificial intelligence-driven platform intended to connect cancer patients to biopharmaceutical clinical trials. The company offers tech-enabled services and a big data platform that addresses the clinical trial enrollment value chain by providing patient identification, pre-screening, and concierge enrollment enablement while being focused on oncology and innovative data, technology, and services, enabling patients to get an effective treatment without disrupting lives and becoming a financial hindrance.

Category
AI
Location
United States
Checked
1h ago

Tags: Health Tech, Healthcare

Massive Bio: questions

Which accelerators did Massive Bio go through?

Massive Bio is listed by 500 Global (Global 2016).

Where is Massive Bio based?

Massive Bio lists United States as its location on 500 Global's page.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.